Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Luminopia
Luminopia scores FDA De Novo for VR treatment for lazy eye
By
Laura Lovett
|
12:42 pm |
October 21, 2021
The tool uses virtual reality to modify media content in order to help children boost their visual acuity.